Pretomanid
Specifications
187235-37-6CAS Number
998-849-3EC Number
(6S)-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazineIUPAC Name
C14H12F3N3O5Chemical Formula
359.26 g/molMolecular Weight
Pretomanid; 187235-37-6; PA-824; PA 824; PA824; 2XOI31YC4N; DTXSID8041163; 2-nitro-6-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo(2,1-b)(1,3)oxazine; (6S)-2-NITRO-6-{[4-(TRIFLUOROMETHOXY)PHENYL]METHOXY}-5H,6H,7H-IMIDAZO[2,1-B][1,3]OXAZINE; (S)-2-NITRO-6-(4-(TRIFLUOROMETHOXY)BENZYLOXY)-6,7-DIHYDRO-5H-IMIDAZO(2,1-B)(1,3)OXAZINE; PA824 cpd; pretomanidum; (6S)-2-nitro-6-((4-(trifluoromethoxy)phenyl)methoxy)-5H,6H,7H-imidazo(2,1-b)(1,3)oxazine; RefChem:57158; DTXCID6021163; (S)-2-Nitro-6-((4-(trifluoromethoxy)benzyl)oxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine; MFCD06809939; (S)-PA 824; (6S)-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine; (6S)-6,7-Dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-5H-imidazo[2,1-b][1,3]oxazine; CHEMBL227875; MMV688755; (S)-PA 824 (Pretomanid); 5H-Imidazo[2,1-b][1,3]oxazine, 6,7-dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-, (6S)-; Pretomanid [USAN:INN]; UNII-2XOI31YC4N; (6S)-2-Nitro-6-{[4-(trifluoromethoxy)phenyl]methoxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine; (S)-2-Nitro-6-[[4-(trifluoromethoxy)benzyl]oxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine; 5H-Imidazo(2,1-b)(1,3)oxazine, 6,7-dihydro-2-nitro-6-((4-(trifluoromethoxy)phenyl)methoxy)-, (6S)-; Pretomanid (Standard); PA-824(Pretomanid); PRETOMANID [MI]; PRETOMANID [INN]; Pretomanid (USAN/INN); PA-824(Pretomanid)?; PRETOMANID [USAN]; Pretomanid(S)-PA 824; PRETOMANID [WHO-DD]; MLS006011141; orb1225841; orb1301077; orb3141401; SCHEMBL2983011; PRETOMANID [ORANGE BOOK]; GTPL11172; ZLHZLMOSPGACSZ-NSHDSACASA-N; GLXC-02683; EX-A1749; BDBM50363237; CS1245; EBC-06939; HY-10844R; s1162; AKOS024464713; CCG-268145; DB05154; DS-7321; FP26721; (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine; NCGC00346682-01; NCGC00346682-02; NCGC00346682-05; NCGC00346682-10; (S)-6,7-Dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-5H-imidazo[2,1-b][1,3]oxazine; AC-25501; DA-66440; HY-10844; SMR004702918; SY105491; NS00069334; P2718; SW220281-1; T6096; D10722; F462409; SR-05000022748; Q7118312; SR-05000022748-1; BRD-K96671969-001-03-1; Z1650127771; (3S)-3-(4-TRIFLUOROMETHOXYBENZYLOXY)-6-NITRO-2H-3,4-DIHYDROIMIDAZO(2,1-B)OXAZINE; (S)-2-Nitro-5-((4-trifluoromethoxyphenyl)methoxy)-7-oxa-1,3a-diaza-5,6-dihydro-4H-indene; {4-[((3S)-6-Nitro(2H,3H,4H-imidazolo[2,1-b]1,3-oxazaperhydroin-3-yloxy))methyl]phenoxy}trifluoromethaneSynonyms
